In addition to exploring GRB7's role in modulating immune cell infiltration across the TME in KICH, KIRC, and PAAD to provide critical insights into its role in tumor progression and its potential as a target for immunotherapy-based strategies. The gene discussed is GRB7; the disease is pancreatic adenocarcinoma.